MYP_059509
Asparaginase
Anticancer
Immunology
▸
Immune modulation
▸
Immunomodulatory activity
Therapeutic / Biomedical activity
▸
Enzyme replacement therapy
Standard
348 amino acids
C1623H2595N439O517S10
Standard
MEFFKKTALAALVMGFSGAALALPNITILATGGTIAGGGDSATKSNYTVGKVGVENLVNAVPQLKDIANVKGEQVVNIGSQDMNDNVWLTLAKKINTDCDKTDGFVITHGTDTMEETAYFLDLTVKCDKPVVMVGAMRPSTSMSADGPFNLYNAVVTAADKASANRGVLVVMNDTVLDGRDVTKTNTTDVATFKSVNYGPLGYIHNGKIDYQRTPARKHTSDTPFDVSKLNELPKVGIVYNYANASDLPAKALVDAGYDGIVSAGVGNGNLYKSVFDTLATAAKTGTAVVRSSRVPTGATTQDAEVDDAKYGFVASGTLNPQKARVLLQLALTQTKDPQQIQQIFNQY
36850.25 Da
5.96
-2.24
-2.72
-0.0064
-0.11
0.58
0.08
18.27
85.46
0.0690
23380.00
23505.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0066448
VERIFIED: NO
Provenance & Taxonomy
Escherichia coli [Bacterium]
Enzyme
562
Structure & Mods
single-chain therapeutic peptide/protein [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Anticancer
Immunomodulatory
Enzyme replacement
8-30 hours
RECORD: Rec_0098877
VERIFIED: NO
Provenance & Taxonomy
Escherichia coli [Bacterium]
Enzyme
562
Structure & Mods
linear peptide/protein therapeutic [Linear]
canonical L-amino-acid peptide [L]
PEGylation
Bio-Activity Profile
Anticancer
Immunomodulatory
Enzyme replacement
Plasma half life of L-asparagine derived from _E. coli_ following intravenous injection was 8-30 hrs [FDA Label]. Plasma half-life was 34 to 49 hours after intramuscular injection [FDA Label]. Half-life (mean ± SD) of native _E. coli_ asparaginase is approximately 1.28 ± 0.35 days [A31999].
RECORD: Rec_0360149
VERIFIED: NO
Provenance & Taxonomy
Escherichia coli [Bacterium]
Enzyme
562
Structure & Mods
linear peptide/protein therapeutic [Linear]
canonical L-amino-acid peptide [L]
PEGylation
Bio-Activity Profile
Anticancer
Enzyme replacement
Plasma half life of L-asparagine derived from _E. coli_ following intravenous injection was 8-30 hrs [FDA Label]. Plasma half-life was 34 to 49 hours after intramuscular injection [FDA Label]. Half-life (mean ± SD) of native _E. coli_ asparaginase is approximately 1.28 ± 0.35 days [A31999].